Treatment of lymphoid tumors with anti-idiotype antibodies.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D001402:B-Lymphocytes / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006168:Guinea Pigs; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D007136:Immunoglobulins / Q000378:metabolism; D007167:Immunotherapy; D066298:In Vitro Techniques; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D051379:Mice
D000888:Antibodies, Anti-Idiotypic; D000912:Antibodies, Neoplasm; D007130:Immunoglobulin Idiotypes; D007136:Immunoglobulins